Stroke Circulatory System Stroke
Conditions
Interventions
1. Patients will be randomised (in blocks of six) to either the intervention or control arm of the study
2. Each arm will have its own multidisciplinary team (MDT)
3. E
Sponsors
University of Strathclyde (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. In patients who have suffered a recent hemiplegia (within 1 - 12 months) 2. Aged 16 - 80 years 3. Have difficulty walking, but able to walk with/without assistance 4. Have difficulty flexing knee and extending hip during walking 5. Meet the criteria for AFO referral as outlined in AFO screening tool (Appendix 9 of NHS Scotland Best Practice Statement 'Use of AFO follwoing stroke') 6. Able to give informed consent 7. Able to attend for follow-up at 3 and 6 months
Exclusion criteria
Exclusion criteria: 1. Unable to give informed consent 2. Unable to walk, even when assisted 3. Suffer from significant peripheral vascular disease - not suitable for fitting of AFO 4. Have any other significant medical problems likely to preclude use of AFO or follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Walking velocity 2. Time taken to complete 10m walk test | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Lower limb joint kinematics (thigh and shank global orientations) & kinetics (knee and hip flexion/extension moments 2. Ground reaction force Fz2 peak magnitude 3. Step length 4. Gait symmetry 5. Modified Ashworth Scale 6. Abbreviated Rivermead Mobility Index 7. EuroQol (EQ-5D) | — |
Countries
United Kingdom
Outcome results
None listed